From past to pandemic: Health disparities in US hepatobiliary cancer mortality before and during COVID-19: Editorial on "Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023".
作者信息
Argirion Ilona
机构信息
Department of Human Science, School of Health, Georgetown University Medical Center, Washington DC, USA.
出版信息
Clin Mol Hepatol. 2025 Jan;31(1):286-289. doi: 10.3350/cmh.2024.0597. Epub 2024 Aug 5.
Abstract
摘要
相似文献
1
From past to pandemic: Health disparities in US hepatobiliary cancer mortality before and during COVID-19: Editorial on "Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023".从过去到疫情：新冠疫情之前及期间美国肝胆癌死亡率的健康差异：关于“2018 - 2023年美国肝细胞癌和胆管癌按种族、族裔和性别划分的死亡率负担”的社论
Clin Mol Hepatol. 2025 Jan;31(1):286-289. doi: 10.3350/cmh.2024.0597. Epub 2024 Aug 5.
2
Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023.2018-2023 年美国按种族、民族和性别划分的肝癌和胆道癌死亡率负担。
Clin Mol Hepatol. 2024 Oct;30(4):756-770. doi: 10.3350/cmh.2024.0318. Epub 2024 Jun 24.
3
Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.医疗机构肝胰胆恶性肿瘤病例数量对非手术治疗的肝胆恶性肿瘤患者生存率的平均治疗效果。
Surgery. 2023 Feb;173(2):289-298. doi: 10.1016/j.surg.2022.10.011. Epub 2022 Nov 17.
4
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.癌症护理在 COVID-19 大流行期间的种族和民族差异。
JAMA Netw Open. 2022 Jul 1;5(7):e2222009. doi: 10.1001/jamanetworkopen.2022.22009.
5
Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century.21 世纪初德国和美国肝胆管和十二指肠癌部位患者的生存情况。
Int J Cancer. 2018 Jul 15;143(2):324-332. doi: 10.1002/ijc.31322. Epub 2018 Mar 5.
6
Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic.新冠大流行期间特定年龄段全因死亡率的种族和民族差异。
JAMA Netw Open. 2024 Oct 1;7(10):e2438918. doi: 10.1001/jamanetworkopen.2024.38918.
7
Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017.胆道癌、胆囊癌和肝癌的发病率和死亡率按性别、年龄、种族/族裔以及诊断时的分期：美国，2013 年至 2017 年。
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1607-1614. doi: 10.1158/1055-9965.EPI-21-0265. Epub 2021 Jul 8.
8
Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.新型靶向治疗策略在胆管癌和肝细胞癌中的应用。
Future Oncol. 2018 Mar;14(6):553-566. doi: 10.2217/fon-2017-0451. Epub 2018 Feb 20.
9
COVID-19 Mortality by Race and Ethnicity in US Metropolitan and Nonmetropolitan Areas, March 2020 to February 2022.2020 年 3 月至 2022 年 2 月美国大都市和非大都市地区按种族和族裔划分的 COVID-19 死亡率。
JAMA Netw Open. 2023 May 1;6(5):e2311098. doi: 10.1001/jamanetworkopen.2023.11098.
10
Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.增加多模态治疗选择提高了肝细胞癌的生存率，但胆道癌的生存率仍未改变。
Eur J Surg Oncol. 2019 Sep;45(9):1660-1667. doi: 10.1016/j.ejso.2019.04.002. Epub 2019 Apr 9.
本文引用的文献
1
Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023.2018-2023 年美国按种族、民族和性别划分的肝癌和胆道癌死亡率负担。
Clin Mol Hepatol. 2024 Oct;30(4):756-770. doi: 10.3350/cmh.2024.0318. Epub 2024 Jun 24.
2
Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12-79 years.美国 12-79 岁人群中代谢功能障碍相关脂肪性肝病的流行率、趋势和特征。
Eur J Gastroenterol Hepatol. 2024 May 1;36(5):636-645. doi: 10.1097/MEG.0000000000002741. Epub 2024 Mar 11.
3
Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic.COVID-19 大流行期间高危胃肠道癌患者的生存情况。
JAMA Netw Open. 2024 Mar 4;7(3):e240160. doi: 10.1001/jamanetworkopen.2024.0160.
4
Current status and future trends of the global burden of MASLD.全球 MASLD 负担的现状和未来趋势。
Trends Endocrinol Metab. 2024 Aug;35(8):697-707. doi: 10.1016/j.tem.2024.02.007. Epub 2024 Feb 29.
5
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
6
Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019.在大多数种族群体中，肝细胞癌的发病率正在下降：SEER-22，2000-2019。
Cancer Med. 2023 Oct;12(19):19960-19967. doi: 10.1002/cam4.6537. Epub 2023 Sep 30.
7
The epidemiological trends of biliary tract cancers in the United States of America.美国胆道癌的流行病学趋势。
BMC Gastroenterol. 2022 Dec 29;22(1):546. doi: 10.1186/s12876-022-02637-8.
8
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.美国胆道癌的流行病学模式：2001-2015 年。
BMC Cancer. 2022 Nov 16;22(1):1178. doi: 10.1186/s12885-022-10286-z.
9
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.个人共病情况及其后续发生肝癌、胆囊癌和胆管癌的风险。
Int J Cancer. 2023 Mar 15;152(6):1107-1114. doi: 10.1002/ijc.34308. Epub 2022 Oct 10.
10
The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017.1990年至2017年195个国家和地区胆囊癌和胆道癌的全球、区域和国家负担及其归因风险因素：全球疾病负担研究2017的系统分析
Cancer. 2021 Jul 1;127(13):2238-2250. doi: 10.1002/cncr.33476. Epub 2021 Mar 22.
Zotero 插件